Cochlear Limited (CHEOF)
OTCMKTS · Delayed Price · Currency is USD
193.04
0.00 (0.00%)
Jul 22, 2025, 8:00 PM EDT
Cochlear Revenue
Cochlear had revenue of 1.17B AUD in the half year ending December 30, 2024, with 32.38% growth. This brings the company's revenue in the last twelve months to 2.31B, up 7.42% year-over-year. In the fiscal year ending June 30, 2024, Cochlear had annual revenue of 2.24B with 15.47% growth.
Revenue (ttm)
2.31B AUD
Revenue Growth
+7.42%
P/S Ratio
9.45
Revenue / Employee
452.99K AUD
Employees
5,097
Market Cap
13.57B USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
Jun 30, 2020 | 1.32B | -106.10M | -7.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Cochlear News
- 8 days ago - Australia news live: Albanese in Chengdu for last leg of China visit; German backpacker leaves hospital after outback ordeal - The Guardian
- 8 days ago - Cochlear CEO calls for tax shake-up to boost R&D - The Australian Financial Review
- 16 days ago - Cochlear Launches World's First and Only Smart Cochlear Implant System - PRNewsWire
- 20 days ago - Cochlear takes fast lane as it brings new hearing device to Chinese market - South China Morning Post
- 6 weeks ago - ASX 200 LIVE: ASX pares gains; Cettire dives 25pc after reporting weak US demand - The Australian Financial Review
- 6 weeks ago - Starkey and MED-EL Announce All-New DualSync Partnership to Advance Bluetooth Connectivity for Cochlear Implant Users - Business Wire
- 7 weeks ago - Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™ - PRNewsWire
- 2 months ago - Labor takes $27m stake in breakthrough eye biotech - The Australian Financial Review